Search results
NeuroBo reports progress in cardiometabolic drug trials By Investing.com
Investing.com· 4 days agoNeuroBo Pharmaceuticals, Inc. (NASDAQ: NASDAQ:NRBO), a biotech firm engaged in developing treatments...
Courtney Butts Nutrition: Is breakfast really the most important meal of the day?
KTBS Shreveport· 2 days agoThere are two types of people: the breakfast-eaters and the breakfast-skippers.
Vitamin D Testing Market Projected to Reach USD 9.98 billion by 2030 Driven by Rising Health...
Digital Journal· 2 days agoThe global vitamin D testing market size is forecasted to reach USD 9.98 billion by 2030, expanding at an impressive compound annual growth rate (CAGR) of 5.1% from 2023 to 2030, according to a new report by SNS Insider The rapidly growing market is
D-Mannose Fails to Prevent Urinary Tract Infections in Women
Medscape· 3 days agoA randomized, double-blind study casts doubt on the effectiveness of a common treatment.
5,705 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Purchased by Raymond James & Associates
ETF DAILY NEWS· 4 days agoRaymond James & Associates acquired a new stake in Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing ...
New regulator of eating behavior identified
Medical Xpress· 4 days agoScientists at Leipzig University and Heinrich Heine University Düsseldorf have now identified a new regulator of eating behavior. The findings have been published in Signal Transduction and ...